Hikma Pharmaceuticals Investor Relations Material
Latest events
H2 2023 (Q&A)
Hikma Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Hikma Pharmaceuticals PLC
Access all reports
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. The company's non-specialty portfolio includes drugs treating diabetes, heart disease, pain management, respiratory disease and other disorders for adults as well as children. The company operates as a regional pharmaceutical company that develops, manufactures, markets and sells a range of generic, branded and its in-licensed products from pain management to oncology.
Key slides for Hikma Pharmaceuticals PLC
J.P. Morgan 42nd Annual Healthcare Conference 2024
Hikma Pharmaceuticals PLC
H1 2023
Hikma Pharmaceuticals PLC
Latest articles
Sundar Pichai: CEO of Alphabet and Google
Explore Sundar Pichai's improbable journey from Chennai, India, to becoming one of the most powerful individuals on the planet.
19 Apr 2024
The Three Cornerstones of Serial Acquirer Success
Explore what is behind successful serial acquirers: efficient capital use, decentralization, and a strong focus on people.
19 Apr 2024
Companies That Had Their IPO in 2023: Cautious Optimism
The cautiously optimistic market in 2023 saw stocks rebounded upwards, and interest in IPOs picked up from the previous year.
15 Apr 2024
Ticker symbol
Country
🇬🇧 United Kingdom